Genetic Deletion of 5-Lipoxygenase Increases Tumor-Infiltrating Macrophages in Apc Δ468 Mice

Journal of Gastrointestinal Surgery

Volumn 16, Issue 2, 2012, Pages 389-393

  Cheon, Eric C ^a,b   Strouch, Matthew J ^b   Krantz, Seth B ^b   Heiferman, Michael J ^b   Bentrem, David J ^b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

5 Lipoxygenase; Colon cancer; Macrophage; Mast cell; Polyp

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE;

ANIMAL; ARTICLE; CELL CULTURE; COLON POLYP; COLON TUMOR; DISEASE MODEL; ENZYMOLOGY; GENETICS; MACROPHAGE; MAST CELL; MOUSE; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELLS, CULTURED; COLONIC NEOPLASMS; COLONIC POLYPS; DISEASE MODELS, ANIMAL; MACROPHAGES; MAST CELLS; MICE; MICE, KNOCKOUT; NEUTROPHILS;

EID: 84856229128     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1761-x     Document Type: Article

References (33)

1. Melstrom LG, Bentrem DJ, Salabat MR, et al.: Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res 2008; 14: 6525-6530.
2. Ohd JF, Nielsen CK, Campbell J, et al.: Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003; 124: 57-70.
3. Ohd JF, Wikstrom K, Sjolander A: Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 2000; 119: 1007-1018.
4. Cheon EC, Khazaie K, Khan MW, et al.: Mast Cell 5-Lipoxygenase Activity Promotes Intestinal Polyposis in APC{Delta}468 Mice. Cancer Res; 71: 1627-1636.
5. Blatner NR, Bonertz A, Beckhove P, et al.: In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci USA; 107: 6430-6435.
6. Gounari F, Chang R, Cowan J, et al.: Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat Immunol 2005; 6: 800-809.
7. Cui S, Reichner JS, Mateo RB, Albina JE: Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 1994; 54: 2462-2467.
8. Martin JH, Edwards SW: Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 1993; 150: 3478-3486.
9. Hansson M, Asea A, Ersson U, et al.: Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 1996; 156: 42-47.
10. Leek RD, Harris AL: Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002; 7: 177-189.
11. Lewis JS, Landers RJ, Underwood JC, et al.: Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 2000; 192: 150-158.
12. Leek RD, Hunt NC, Landers RJ, et al.: Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000; 190: 430-436.
13. Arnott CH, Scott KA, Moore RJ, et al.: Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene 2002; 21: 4728-4738.
14. Funada Y, Noguchi T, Kikuchi R, et al.: Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 2003; 10: 309-313.
15. Forssell J, Oberg A, Henriksson ML, et al.: High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13: 1472-1479.
16. Nakayama Y, Nagashima N, Minagawa N, et al.: Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res 2002; 22: 4291-4296.
17. Tan SY, Fan Y, Luo HS, et al.: Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 2005; 11: 1210-1214.
18. Lee AH, Happerfield LC, Bobrow LG, Millis RR: Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 1997; 50: 669-673.
19. Leek RD, Lewis CE, Whitehouse R, et al.: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56: 4625-4629.
20. Nishie A, Ono M, Shono T, et al.: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999; 5: 1107-1113.
21. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T: Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000; 60: 2632-2635.
22. Roncucci L, Mora E, Mariani F, et al.: Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 2291-2297.
23. Popivanova BK, Kitamura K, Wu Y, et al.: Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008; 118: 560-570.
24. Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM: Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int J Exp Pathol 2008; 89: 466-475.
25. Gurish MF, Tao H, Abonia JP, et al.: Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing. J Exp Med 2001; 194: 1243-1252.
26. Jiang Y, Kanaoka Y, Feng C, et al.: Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling. J Immunol 2006; 177: 2755-2759.
27. Olynych TJ, Jakeman DL, Marshall JS: Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol 2006; 118: 837-843.
28. Corrigan C, Mallett K, Ying S, et al.: Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol 2005; 115: 316-322.
29. Figueroa DJ, Borish L, Baramki D, et al.: Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 2003; 33: 1380-1388.
30. Figueroa DJ, Breyer RM, Defoe SK, et al.: Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163: 226-233.
31. Heinsbroek SE, Taylor PR, Rosas M, et al.: Expression of functionally different dectin-1 isoforms by murine macrophages. J Immunol 2006; 176: 5513-5518.
32. Xing Z, Zganiacz A, Santosuosso M: Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction. J Leukoc Biol 2000; 68: 897-902.
33. Ford-Hutchinson AW, Bray MA, Doig MV, et al.: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264-265.